Suchergebnisse - "Diver, Sarah"

PubPharm (6)

1

Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma

enthalten in: NEJM evidence | 2023

von Nordenmark, L. | Hellqvist, �. | Emson, C. | +10

2

Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE) : a double-blind, randomised, placebo-controlled, phase 2 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Diver, S. | Khalfaoui, L. | Emson, C. | +10

ErratumIn: Lancet Respir Med. 2021 Nov;9(11):e106. - PMID 34739888

3

The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study) : a prospective observational study

enthalten in: The Lancet. Respiratory medicine | 2021

von McDowell, P. | Diver, S. | Yang, F. | +41

4

CASCADE : a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma

enthalten in: Respiratory research | 2020

von Emson, C. | Diver, S. | Chachi, L. | +7

5

Mepolizumab does not alter the blood basophil count in severe asthma

enthalten in: Allergy | 2019

von Wright, A. | Diver, S. | McCarthy, J. | +13

6

Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma

enthalten in: The European respiratory journal | 2019

von Chachi, L. | Diver, S. | Kaul, H. | +5

1
[1]